Voice Alteration
7
0
0
3
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 72/100
14.3%
1 terminated out of 7 trials
75.0%
-11.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (7)
PhoRTE® Therapy Efficacy: In-Person Versus Telehealth
Effects of Finger Kazoo Exercise With and Without Oropharyngeal Enlargement in the Operatic Singing Voice
Gender-affirming Voice Training With Visual Feedback
Evaluation of Functions of Swallowing and Voice in Ankylosing Spondylitis Patients
Intubation Tube Applications on Voice Performance in Early Postoperative Period
The Influence of Significant Weight Lost on the Quality of Voice
Impact of Total Thyroidectomy on Voice and Swallowing